Broadly Neutralizing Antibodies (bnAbs) Against HIV: Overview

Broadly neutralizing antibodies (bnAbs) are immune proteins that recognize and bind conserved regions of the HIV envelope protein, blocking infection across diverse HIV strains. They develop in some long-term HIV controllers.

Notable bnAbs

  • VRC01: Binds CD4 binding site; isolated from a 20+ year non-progressor; broad strain coverage.
  • PG9: Binds V1/V2 glycan site; from a 10+ year non-progressor; complementary strain coverage.
  • PGT121: Binds V3 glycan site; from a 15+ year non-progressor; distinct strain coverage.

Therapeutic Potential

bnAbs are under investigation for HIV treatment, prevention, and potential cure strategies due to their breadth and durability.

HIV & AIDS - Related Articles